Corbus Pharmaceuticals Holdings, Inc. (CRBP)

CRBP Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	513	27	14	77	105	353
Market Cap Growth	1257.77%	93.01%	-82.05%	-26.60%	-70.25%	5.64%
Enterprise Value	410	26	-21	5	45	331
PE Ratio	-	-0.60	-0.33	-1.69	-0.94	-4.94
PS Ratio	-	-	-	87.45	26.68	9.77
PB Ratio	5.29	-3.87	0.42	1.12	2.32	57.35
P/FCF Ratio	-14.22	-0.74	-0.37	-1.60	-1.05	-7.29
P/OCF Ratio	-14.22	-0.74	-0.37	-1.60	-1.05	-7.72
EV/Sales Ratio	-	-	-	6.10	11.54	9.15
EV/EBITDA Ratio	-10.03	-0.63	0.53	-0.13	-0.42	-4.63
EV/EBIT Ratio	-9.84	-0.62	0.52	-0.12	-0.41	-4.55
EV/FCF Ratio	-10.65	-0.72	0.56	-0.11	-0.45	-6.83
Debt / Equity Ratio	0.18	-3.02	0.76	0.38	0.59	1.53
Debt / EBITDA Ratio	-0.56	-0.51	-0.64	-0.63	-0.25	-0.13
Debt / FCF Ratio	-0.60	-0.58	-0.67	-0.55	-0.27	-0.19
Quick Ratio	4.66	0.68	4.74	5.78	2.71	0.91
Current Ratio	4.69	0.74	4.76	5.89	2.89	1.09
Asset Turnover	0	0	0	0.01	0.04	0.48
Interest Coverage	-12.93	-14.25	-18.86	-23.93	-107.20	-
Return on Equity (ROE)	-135.20%	-920.30%	-91.30%	-57.90%	-305.70%	-227.80%
Return on Assets (ROA)	-57.70%	-111.60%	-53.30%	-37.40%	-123.10%	-94.40%
Return on Capital (ROIC)	-32.74%	-322.45%	-68.59%	-58.51%	-170.31%	-494.16%
Earnings Yield	-6.58%	-166.93%	-305.90%	-59.19%	-105.92%	-20.24%
FCF Yield	-5.64%	-135.11%	-271.24%	-62.53%	-95.36%	-13.72%
Buyback Yield / Dilution	-98.74%	-3.76%	-1.85%	-57.23%	-22.28%	-12.10%
Total Shareholder Return	-98.74%	-3.76%	-1.85%	-57.23%	-22.28%	-12.10%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).